Pharmaron Beijing Co Ltd (300759) — Capital Reinvestment Ratio
Latest as of September 2025:
0.72x
Pharmaron Beijing Co Ltd (300759) has a Capital Reinvestment Ratio of 0.72x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥1.04 Billion) in capital expenditures (CN¥746.35 Million). See 300759 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.72x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥1.04 Billion
CNY
Capital Expenditures
CN¥746.35 Million
CNY
Data as of
Sep 2025
Most recent filing
Pharmaron Beijing Co Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks Pharmaron Beijing Co Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Pharmaron Beijing Co Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for Pharmaron Beijing Co Ltd from 2014 to 2024. For live market cap and broader valuation context, see Pharmaron Beijing Co Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.79x | CN¥2.58 Billion | CN¥2.04 Billion | ▼ -23.9% |
| 2023 | 1.04x | CN¥2.75 Billion | CN¥2.87 Billion | ▼ -24.4% |
| 2022 | 1.38x | CN¥2.14 Billion | CN¥2.95 Billion | ▲ +35.4% |
| 2021 | 1.02x | CN¥2.06 Billion | CN¥2.09 Billion | ▲ +27.4% |
| 2020 | 0.80x | CN¥1.65 Billion | CN¥1.32 Billion | ▼ -0.7% |
| 2019 | 0.80x | CN¥938.59 Million | CN¥754.61 Million | ▼ -7.5% |
| 2018 | 0.87x | CN¥737.26 Million | CN¥640.99 Million | ▼ -48.6% |
| 2017 | 1.69x | CN¥552.22 Million | CN¥934.67 Million | ▼ -62.2% |
| 2016 | 4.48x | CN¥235.77 Million | CN¥1.06 Billion | ▲ +276.0% |
| 2015 | 1.19x | CN¥216.94 Million | CN¥258.32 Million | ▼ -82.4% |
| 2014 | 6.75x | CN¥12.13 Million | CN¥81.94 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow